phase readout
saveNCT07598448: A Study of Complement 3 Glomerulopathy (C3G) Patients Treated With Iptacopan Through an Early Access Program in Spain
NOT_YET_RECRUITINGupdated 36m ago
community read0 votes
Sponsor: Novartis Pharmaceuticals. Phase: . Conditions: Complement 3 Glomerulopathy
view source ↗
comments(0)
5-min edit window · permanent after that